[1] Anene C, Graham AM, Boyne J, et al.Platelet microparticle delivered microRNA-Let-7a promotes the angiogenic switch[J]. Biochim Biophys Acta Mol Basis Dis, 2018 ,1864(8):2633-2643. [2] Zacharia E, Antonopoulos AS, Oikonomou E, et al.Plasma signature of apoptotic microvesicles is associated with endothelial dysfunction and plaque rupture in acute coronary syndromes[J]. J Mol Cell Cardiol, 2020 ,138:110-114. [3] Preston RA, Jy W, Jimenez JJ, et al.Effects of severe hypertension on endothelial and platelet microparticles[J]. Hypertension.,2003,41(2):211-217. [4] Whelton PK, Carey RM, Aronow WS, et al.2017 ACC/AHA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines[J]. Hypertension, 2018,71(6):e13-e115. [5] WilliamS B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension[J]. Kardiol Pol, 2019,77(2):71-159. [6] 中国高血压防治指南修订委员会.中国高血压防治指南(2018年修订版)[J].中国心血管杂志,2019,24(1):24-56. [7] Zeng L, Zhang Z, Wang X, et al.Correlations of Circadian Rhythm Disorder of Blood Pressure with Arrhythmia and Target Organ Damage in Hypertensive Patients[J]. Med Sci Monit, 2019, 25:7808-7812. [8] Yang WY, Melgarejo JD, Thijs L, et al.International Database on Ambulatory Blood Pressure in Relation to Cardiovascular Outcomes (IDACO) Investigators. Association of Office and Ambulatory Blood Pressure With Mortality and Cardiovascular Outcomes[J]. JAMA, 2019,322(5):409-420. [9] Kario K, Shin J, Chen CH, et al.Expert panel consensus recommendations for ambulatory blood pressure monitoring in Asia: The HOPE Asia Network[J]. J Clin Hypertens (Greenwich), 2019,21(9):1250-1283. [10] 2020中国动态血压监测指南[J].中国循环杂志,2021,36(4):313-328. [11] Alarcón M.Generation of platelet-derived microparticles through the activation of the toll-like receptor 4[J]. Heliyon, 2019,5(4):e01486. [12] Wang GH, Ma KL, Zhang Y, et al.Platelet microparticles contribute to aortic vascular endothelial injury in diabetes via the mTORC1 pathway[J]. Acta Pharmacol Sin, 2019,40(4):468-476. [13] Kong L, Li K, Gao L, et al.Mediating effects of platelet-derived extracellular vesicles on PM2.5-induced vascular endothelial injury[J]. Ecotoxicol Environ Saf, 2020,198:110652. [14] Diehl P, Nienaber F, Zaldivia MTK, et al.Lysophosphatidylcholine is a Major Component of Platelet Microvesicles Promoting Platelet Activation and Reporting Atherosclerotic Plaque Instability[J]. Thromb Haemost, 2019,119(8):1295-1310. [15] Zacharia E, Antonopoulos AS, Oikonomou E, et al.Plasma signature of apoptotic microvesicles is associated with endothelial dysfunction and plaque rupture in acute coronary syndromes[J]. J Mol Cell Cardiol, 2020,138:110-114. [16] Laffont B, Corduan A, Rousseau M, et al.Platelet microparticles reprogram macrophage gene expression and function[J]. Thromb Haemost, 2016, 115(2):311-23. [17] Bao H, Yao QP, Huang K, et al.Platelet-derived miR-142-3p induces apoptosis of endothelial cells in hypertension[J]. Cell Mol Biol (Noisy-le-grand), 2017, 63(4):3-9. [18] De la Sierra A, Redon J, Banegas JR, et al. Prevalence and factors associated with circadian blood pressure patterns in hypertensive patients[J]. Hypertension, 2009,53(3):466-72. [19] Andreadis EA, agaliotis G, kollias A, et al. Night-time home versus ambulatory blood pressure in determining target organ damage[J]. J Hypertens, 2016,34(3):438-444. [20] Hu SS, Zhang HG, Zhang QJ, et al.Circulating CD62P small microparticles levels are increased in hypertension[J]. Int J Clin Exp Pathol, 2014,7(8):5324-5326. [21] 李乾豪,仉红刚,张秋菊,等.高血压伴肥胖患者血浆CD31+/CD42b+血小板来源微泡研究[J].中国实验诊断学,2017,21(6):935-938. [22] Alexandru N, Popov D, Dragan E, et al.Circulating endothelial progenitor cell and platelet microparticle impact on platelet activation in hypertension associated with hypercholesterolemia[J]. PLoS One, 2013,8(1):e52058. [23] Recabarren-Leiva D, Alarcón M.Standardization of a fast and effective method for the generation and detection of platelet-derived microparticles by a flow cytometer[J]. Immunol Lett, 2018,194:79-84. [24] Rosińska J, Ukasik M, Kozubski W.The Impact of Vascular Disease Treatment on Platelet-Derived Microvesicles[J]. Cardiovasc Drugs Ther, 2017,31(5-6):627-644. [25] Rosińska J, Ambrosius W, Maciejewska J, et al.Association of platelet-derived microvesicles and their phenotypes with carotid atherosclerosis and recurrent vascular events in patients after ischemic stroke[J]. Thromb Res, 2019,176:18-26. |